TY - JOUR T1 - The cost of tuberculosis sequelae JF - European Respiratory Journal JO - Eur Respir J SP - 824 LP - 825 DO - 10.1183/09031936.00091414 VL - 44 IS - 3 AU - Roland Diel Y1 - 2014/09/01 UR - http://erj.ersjournals.com/content/44/3/824.abstract N2 - From the author:We thank A. Proaño and co-workers for their important comments on our cost analysis of tuberculosis (TB) in the European Union [1]. As pointed out in our study, the cost calculation only refers to direct treatment costs of the disease itself under the implicit assumption that treatment success has either been gained over 24 months or, alternatively, that according to the official World Health Organization data a minor percentage of patients (shown separately for fully susceptible TB and multidrug-resistant (MDR)-TB) will die immediately afterwards. In addition, to our knowledge, the disability weight … ER -